BAMCO Inc’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.93M Buy
+5,000
New +$1.85M ﹤0.01% 287
2024
Q4
Sell
-11,600
Closed -$6.03M 322
2024
Q3
$6.03M Hold
11,600
0.02% 255
2024
Q2
$6.29M Buy
11,600
+2,600
+29% +$1.37M 0.02% 253
2024
Q1
$4.67M Buy
9,000
+2,300
+34% +$1.14M 0.01% 271
2023
Q4
$3.16M Hold
6,700
0.01% 279
2023
Q3
$2.92M Sell
6,700
-2,700
-29% -$1.22M 0.01% 280
2023
Q2
$4.18M Sell
9,400
-3,100
-25% -$1.43M 0.01% 270
2023
Q1
$5.75M Buy
12,500
+900
+8% +$428K 0.02% 255
2022
Q4
$5.95M Hold
11,600
0.02% 260
2022
Q3
$5.27M Buy
+11,600
New +$5.55M 0.02% 268
2022
Q2
Sell
-9,600
Closed -$4.72M 376
2022
Q1
$4.72M Buy
+9,600
New +$4.39M 0.01% 307

Other funds holding ELV

BAMCO Inc's ELV Position: Q2 2026 in Review

BAMCO Inc opened a new position in Elevance Health (ELV) in Q2 2026: 5,000 shares worth $1.93M. The stake represents ﹤0.01% of the portfolio and ranks #287 among its holdings. This is a return to the name: BAMCO Inc previously reported a position in ELV as recently as Q3 2024.

BAMCO Inc first reported a position in ELV in Q1 2022 and has held it in 11 quarters since. The position peaked at $6.29M in Q2 2024. 1,604 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • BAMCO Inc held 5,000 shares of Elevance Health worth $1.93M as of Q2 2026.
  • Elevance Health was a new BAMCO Inc position in Q2 2026.
  • Elevance Health made up ﹤0.01% of BAMCO Inc's portfolio in Q2 2026, its #287 holding.
  • BAMCO Inc first reported a position in Elevance Health in Q1 2022 and has held it in 11 quarters since.
  • BAMCO Inc's Elevance Health position peaked at $6.29M in Q2 2024.
  • 1,604 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on BAMCO Inc's 13F filing for Q2 2026, filed 14 Aug 2026.